These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35714175)

  • 1. Th17 cell-linked mechanisms mediate vascular dysfunction induced by testosterone in a mouse model of gender-affirming hormone therapy.
    Santos JD; Oliveira-Neto JT; Barros PR; Damasceno LEA; Lautherbach N; Assis AP; Silva CAA; Sorgi CA; Faccioli LH; Kettelhut IC; Salgado HC; Carneiro FS; Alves-Filho JC; Tostes RC
    Am J Physiol Heart Circ Physiol; 2022 Aug; 323(2):H322-H335. PubMed ID: 35714175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiovascular subtleties of testosterone on gender-affirming hormone therapy.
    Santos JD; Oliveira-Neto JT; Tostes RC
    Am J Physiol Heart Circ Physiol; 2023 Jul; 325(1):H30-H53. PubMed ID: 37145958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
    Schneider F; Wistuba J; Holterhus PM; Kulle A; Schlatt S; Kliesch S; Neuhaus N; Zitzmann M
    J Sex Med; 2021 Oct; 18(10):1807-1817. PubMed ID: 34600646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease in transgender individuals.
    Murphy CN; Delles C; Davies E; Connelly PJ
    Atherosclerosis; 2023 Nov; 384():117282. PubMed ID: 37821271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
    Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
    LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
    [No Abstract]   [Full Text] [Related]  

  • 8. Transgender healthcare: metabolic outcomes and cardiovascular risk.
    Glintborg D; Christensen LL; Andersen MS
    Diabetologia; 2024 Jul; ():. PubMed ID: 38958699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough Bleeding in Transgender and Gender Diverse Adolescents and Young Adults on Long-Term Testosterone.
    Grimstad F; Kremen J; Shim J; Charlton BM; Boskey ER
    J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):706-716. PubMed ID: 33910088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding upon the relationship between gender-affirming hormone therapy, neural connectivity, mental health, and body image dissatisfaction.
    Grannis C; Mattson WI; Leibowitz SF; Nahata L; Chen D; Strang JF; Thobe H; Indyk JA; Nelson EE
    Psychoneuroendocrinology; 2023 Oct; 156():106319. PubMed ID: 37331310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Animal Models Investigating the Reproductive Effects of Gender-Affirming Hormone Therapy.
    Raja NS; Rubin ES; Moravek MB
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of sex hormone use on sleep architecture in a transgender cohort.
    Morssinkhof MWL; van der Werf YD; van den Heuvel OA; van den Ende DA; van der Tuuk K; den Heijer M; Broekman BFP
    Sleep; 2023 Nov; 46(11):. PubMed ID: 37715990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
    J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
    Morssinkhof MWL; Wiepjes CM; Bosman BW; Kinds J; Fisher AD; Greenman Y; Kreukels BPC; T'Sjoen G; van der Werf YD; Heijer MD; Broekman BFP
    Sleep Med; 2023 Jul; 107():316-326. PubMed ID: 37271109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
    Ong C; Monita M; Liu M
    Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
    Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
    J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review.
    Ferraro JJ; Reynolds A; Edoigiawerie S; Seu MY; Horen SR; Aminzada A; Hamidian Jahromi A
    World J Methodol; 2022 Nov; 12(6):465-475. PubMed ID: 36479311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotype changes after sex hormone use: A prospective cohort study in transgender users of gender-affirming hormones.
    Morssinkhof MWL; Zwager A; van der Tuuk K; den Heijer M; van der Werf YD; Stenvers DJ; Broekman BFP
    Chronobiol Int; 2024 May; 41(5):658-668. PubMed ID: 38616311
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.